Scroll To Top

biktarvy

A New Once-Daily Pill to Treat HIV Just Got the FDA’s Green Light

Bixlenvo offers a simplified option for patients whose HIV is under control but who can’t use current single-pill treatments.

The FDA Says This Group Can Now Use Biktarvy Safely

The once-daily regimen for those with HIV can now be prescribed to those with a common treatment resistance.

New Research Shows Long-Acting Injectable is Preferable to Pills

Ninety percent of study participants preferred the every-two-month HIV treatment regimen over taking a daily pill.